Blog

A Roth IRA can be an incredibly powerful tool for your retirement. Key benefits it can bring you include:

With all those benefits in mind, becoming a Roth IRA millionaire is a wonderful goal to set

"Exponential" is defined as "growing" or "increasing very rapidly." Here's a good way to use it in a sentence: Saving and investing early and often is a clear path to creating exponential wealth.

If

A sum of $500 might not seem like much of an investment, but if you select the right pharmaceutical stocks -- and are patient enough to hold them forever -- history shows you'll have a very high

Vertex Pharmaceuticals (NASDAQ: VRTX) is a fast-growing pharmaceutical company that investors have been bullish on for years. The business generates billions in revenue from cystic fibrosis drugs

The capital markets are off to a sizzling start so far in 2024. The S&P 500 and Nasdaq Composite have each gained approximately 11% thanks to artificial intelligence euphoria, a strong energy

As its shareholders already know, CRISPR Therapeutics (NASDAQ: CRSP) has quite a few opportunities on the table. Between its commercialized medicine, a pipeline that's packed with chances to mint

The artificial intelligence (AI) revolution is well underway. Kickstarted by OpenAI's ChatGPT introduction near the end of 2022, surging interest in generative AI and machine learning systems has

There are still some businesses reporting their most recent quarterly results. AutoZone (NYSE: AZO) is one of them. The aftermarket auto parts retail chain beat Wall Street estimates when it came to

Viking Therapeutics (NASDAQ: VKTX) stock is soaring. Two years ago, the share price hovered just above $2. Today, shares trade around $62. At Friday's prices, a paltry $100 investment in 2022 would

Dividend stocks can be boring, especially when AI-fueled stock gains are proliferating. Still, for long-term investors, buying sustainable dividend stocks with solid growth potential is a timeless

Raging hot inflation has made it harder to find value in anything these days. A $20 bill doesn't go as far as it once did. But don't get discouraged; that money can go a long way if you know where

Nvidia (NASDAQ: NVDA) has been a great stock to own, and it could remain that way for long-term investors. However, the problem is that it's trading at nearly 40 times its future profits. At such a

Most investors who buy tech stocks do so for the potential for high growth and share price appreciation. Considering that the biggest winners over the past decade have been tech stocks, this makes

The stock market has gotten off to a sizzling start in 2024. Both the S&P 500 and Nasdaq Composite have gained roughly 11% on the backdrop of strong tailwinds in the technology and energy sectors in

Shares of cybersecurity powerhouse Palo Alto Networks (NASDAQ: PANW) experienced a resurgence in recent weeks, rising past $300. That is, until May 20, when the company reported earnings for its

Jamie Dimon, the CEO of JPMorgan Chase (NYSE: JPM), is one of the most listened-to voices in finance. His words, which often reveal to everyday investors how the royalty of Wall Street views the

Shares of Bank of America (NYSE: BAC) have done quite well recently. As of this writing, they have soared 30% just in the past six months (as of May 21), a gain that outpaces the S&P 500. Perhaps

Natural gas storage plays a vital role in the energy sector. Gas storage facilities help balance natural gas demand between seasons and during periods of disruption from storms and other factors.

Dividend-paying tech stocks were once a rare breed. But this year big names in tech have suddenly started offering dividends. For example, Salesforce and Facebook parent Meta Platforms both

Fool.com contributor Parkev Tatevosian reviews why everyone is discussing Nvidia (NASDAQ: NVDA) stock.

*Stock prices used were the afternoon prices of May 23, 2024. The video was published on May

It would probably be a mistake to simply forget about net-lease giant Realty Income (NYSE: O). It is a well-run company, but it poses some problems for investors when you dig into the story a bit

One of billionaire Stanley Druckenmiller's more notable stock positions is a stake in Coupang (NYSE: CPNG). The fund of his Duquesne Family Office initially acquired shares in the company in the

With some promising clinical trial results in hand and more that could be on the way relatively soon, Amgen's (NASDAQ: AMGN) latest attempt to develop a therapy for obesity is looking like it could

The past two-and-a-half years have been rough for Moderna (NASDAQ: MRNA). Though the biotech was highly successful in the COVID-19 vaccine market, investors rightly expecting this niche to shrink

Many investors seek small-cap stocks with the potential to dominate their niche, as their small size prevents them from being significantly owned by large firms. Additionally, because of their small